|Articles|June 24, 2013

News from DIA 2013

News and Updates from DIA 2013

BBK Worldwide Mobilizes 7,000 Attendees of the Drug Information Association Annual Meeting to Be "Boston Strong"

IMS Greenphire Demo eClinicalGPS and GrantPlan Integration

Exco InTouch Unveils New Website and Program for DIA 2013 49th Annual Meeting

LabConnect to Showcase Innovative Ambient Sample Shipping System at DIA

Virtify Will be Making a $5 Contribution to the The One Fund Boston for Each Visitor to Their Booth

SynteractHCR Launches Intelligent Clinical Development Platform at DIA 2013 to Support Trial Efficiencies Globally

Australian CRO Novotech Announces Expanded Asia Reach into Hong Kong and Philippines at DIA 2013

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

Image Credit: Adobe Stock Images/Lisa. High grade follicular lymphoma with marginal zone differentiation.

AbbVie and Genmab Secure FDA Approval for Epkinly Combination in Second-Line Plus Follicular Lymphoma

ByDavy James

November 19th 2025

© putilov_denis - © putilov_denis - stock.adobe.com

The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials

ByGavin Hershaw,Natalia Kotchie,Jessica Taylor Jones,Sabrina Steffen

November 19th 2025

Managing Operational and Compliance Challenges on Emerging Platforms

ByChristian Bullock,Andy Studna, Senior Editor

November 19th 2025

Ziihera Combinations Show Significant Survival Benefits in Phase III HER2+ GEA Trial

ByAndy Studna, Senior Editor

November 18th 2025

ACT Brief: Digital Recruitment Strategies, Tremfya’s Long-Term PsA Results, and Agentic AI’s Enterprise Impact

ByAndy Studna, Senior Editor

November 18th 2025

News from DIA 2013

Newsletter

Related Content

AbbVie and Genmab Secure FDA Approval for Epkinly Combination in Second-Line Plus Follicular Lymphoma

The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials

Managing Operational and Compliance Challenges on Emerging Platforms

Ziihera Combinations Show Significant Survival Benefits in Phase III HER2+ GEA Trial

ACT Brief: Digital Recruitment Strategies, Tremfya’s Long-Term PsA Results, and Agentic AI’s Enterprise Impact

Trending on Applied Clinical Trials Online

AbbVie and Genmab Secure FDA Approval for Epkinly Combination in Second-Line Plus Follicular Lymphoma

The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials

Managing Operational and Compliance Challenges on Emerging Platforms

Ziihera Combinations Show Significant Survival Benefits in Phase III HER2+ GEA Trial

ACT Brief: Digital Recruitment Strategies, Tremfya’s Long-Term PsA Results, and Agentic AI’s Enterprise Impact